<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical c...

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a...

    Filing Type:    PU
    Erytech Pharma S.A.

    Erytech Pharma S.A.

    Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical com...

    Founded in Lyon, France in 2004, ERYTECH is a c...

    Filing Type:    PU
    NuVasive, Inc.

    NuVasive, Inc.

    NuVasive is a world leader in minimally invasive, procedurally integrated spine so...

    NuVasive is a world leader in minimally invasiv...

    Filing Type:    PU
    Eclipse Diagnostics Inc.

    Eclipse Diagnostics Inc.

    Eclipes Diagnostics develops CANABINOX, a handheld testing device that can accurat...

    Eclipes Diagnostics develops CANABINOX, a handh...

    Amount Raised:    $171,800.00
    Fundraising Status:    EC
    Filing Type:    CF
    CHF Solutions, Inc.

    CHF Solutions, Inc.

    CHF Solutions is focused on improving the quality of life for patients suffering f...

    CHF Solutions is focused on improving the quali...

    Filing Type:    PU
    Roche Holding Ltd

    Roche Holding Ltd

    Together, a potent new drug and a blood test to guide its use can be a life change...

    Together, a potent new drug and a blood test to...

    Filing Type:    PU
    Livongo Health, Inc.

    Livongo Health, Inc.

    Livongo Health, Inc. (NASDAQ: LVGO) is a leading Applied Health Signals company em...

    Livongo Health, Inc. (NASDAQ: LVGO) is a leadin...

    Filing Type:    PU
    IntriCon Corporation

    IntriCon Corporation

    For more than 40 years, IntriCon has been meeting the rising demand for smaller, p...

    For more than 40 years, IntriCon has been meeti...

    Filing Type:    PU
    SiNtx Technologies, Inc.

    SiNtx Technologies, Inc.

    SINTX Technologies is a commercial biomaterial company focused on using its silico...

    SINTX Technologies is a commercial biomaterial ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.